Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain September 9, 2019 - NASDAQ Companies 0 » View More News for September 09, 2019
